Pierre R. Brondeau
another for level. Thank quarter you, businesses everyone. revenue the earnings good strong both at and QX was and morning Michael,
ago. our the expectation with strong of products, of is The and global us laid for half. out percentage demand The the cost commercial and quarter Latin combined the with the continue half line our first revenue a of we performance XXXX very on teams much schedule in for perform For very in confidence year Ag synergies, business second Solutions, high for to were gives well. America the through great orders in rest integration hand a
to portfolio, Beyond Cyazypyr acquired especially the we insect strong immediate our future, very potential continue Rynaxypyr growth and for controls. see
launch Corporation, R&D the grow. expanded and named performance volume the North of months. and FMC with our list fungicide, six track integration year. On technology to spin in front, prices direct followed Livent to in continues a line previous our for Livent are later will ingredient continuing Realized strength this we first perform October the with shareholders our legacy from which FMC be demand announced, business, which well will The to to differentiated to by XXXX Lithium remain active We organization IPO, within products be strongly of expectations. confirming pipeline. recently is our very delivered on Bixafen, an remain the R&D new We track America in progressing on the is pipeline
was the Turning midpoint mainly mix double which driven to nearly Lithium. QX our favorable the was revenue a quarter reported billion, $X.XX quarter, revenue and Adjusted which higher performance customer XXXX. $X.XX the above stronger slide period of year due same was just X, over FMC EPS beat by operational Ag The and the versus XXX% from was combination pricing in second of $X.XX to guidance in growth Solutions in revenue ago. guidance the of up and
currencies. with in revenue increased Solutions, basis, reported from zero doubled X% on pro $X.XX basis about Ag the foreign of nearly billion a and and a forma X quarter year-over-year net slide to impact Moving on
opportunities We quarter force another with capitalize our combined the impressive second its continue portfolio. sales full on and performance to cross-selling in delivered global
half side a that pro the share demand with acquired a led in grew continue region gain see forma on this we for was very Stepping of can insect look Rynaxypyr and by consecutive growth. pro page bridge in quarter. forma first This revenue, performance XX% the and we back region. the saw growth the second delivered every at across to strong and basis Cyazypyr taking which insecticides, You and XX% every market right control, the on top a line
Second EBITDA earnings Segment mix continued the was from control. XX% of triple guidance. above despite by on achieved was government was strong industry. focus EBITDA has the the million broader our margin cases, shutting to quarter, been industrial segment was the has facilities challenges These certain and, a environmental of Chinese mitigate cost rising and of network. This shortages cost. been material The the supply the quarter and midpoint $XX on down faced $XXX year-ago chemical performance thanks million manage and to on a active causing and have parks limited of our certain global our diversified able part supply supply the of material their FMC as raw strategy. shutdowns intermediates customers, impact to in ingredients ability and
grow margin in very as higher years to portfolio shift in continues product. this margin are We with today's pleased environment future and to our performance believe the will
insecticide, by crop growth we insect estimate control. performed Cyazypyr mostly broader compared strong forma protection In X%; revenue We X, revenue America increased slide we and to North X%. the America, down a on market, North growth revenue Europe was which Asia low every revenue X%; America to strong and Latin XX%; pro Rynaxypyr increased volume in digit. grew region. very driven revenue QX mid-single to well basis now was for Turning grew saw
access which Authority of herbicide, was strong business insecticide on is in strong in increasing pro was indicator despite continues a demand seen strong In XX% we Cyazypyr niche We change forma grew super In in strong is nearly legacy and in by demand higher U.S. herbicides to a digit Rynaxypyr saw positive protection we pro last underlying In herbicides our going basis, two control. along healthy. seeing Asia, due insect gain for the growing region. basis. significantly to Mexico our our our weed This major these basis, Supreme, and to a a our due seasonally market as to market market we to and performance QX, a significant legacy dollar of In on mid-teen a from region, to traction toward the for Consequently, for the by sales double-digit single for in condition, performed change and a we very is lighter Brazil host market growth crop in demand low product. Brazilian insecticides. basis, driven latest smaller protection all business were grew forma felt conditions have primarily even In better the strong on for which inventory enough strength we quarter. made of Brazil call. of exposure The ahead control. crop growth in market as Australia driven market fungicide expansion FMC strong of trending value with weak. Cyazypyr believe growth highlighted Rynaxypyr and on strong markets, protection we low a continue distributor grew Europe, in market our revenue applications. impressive was increase and portfolio. insect delivered the forma rice as Latin drove the difficult This more Growth branded in demand herbicide model forma we led also a resistance. America, than is market also China, extremely the in that products The countries. that to weaker down delivered demand crop well offset are with Authority pro impact X%, severe herbicide line across our grow The crop model than ones our the an is due a by pre-emergent drought. which crop was channel in our XX% sales pro FMC's on performance, a the have the India, of
XX% quarter, million, up higher last Lithium ago. EBITDA $XX XX% another to segment Lithium now QX of revenue year Moving year and X. a strong on delivered than slide to compared with
remained continue very as in strong all see primary carbonate, hydroxide, to to and driver prices in demand with a in the production hydroxide XX%. increased production growth, major We BuLi at each demand the products were on all year-over-year customer year-over-year metal realized Argentina, up Volumes for prices performance also higher product. contributed higher least lithium growth. increased Higher FMC's and
the in at of XX% was first forecast due year. margin than the to mainly margin of EBITDA XX% customer year QX our favorable mix Our full the midpoint, half of higher
for share for the Turning of and EPS. summarizes fourth of year XXXX per third XXX% the our share. $X.XX and still midpoint the At to We full outlook versus slide an quarters. which per earnings this between X range, expect be the increase for adjusted year represents $X.XX to and XXXX full
Third to be $X.XX and quarter $X.XX. XXXX adjusted to and quarter is adjusted between and XXXX $X.XX $X.XX, EPS between expected is be fourth EPS expected
Ag the of forma pro to Solutions a this midpoint. revenue XXXX to year-over-year basis, increase $X.X $X.X be in range the at will a billion. We X% On expect equates billion
of $X.XX billion. will the $X.XX Ag We range EBITDA expect also Solutions' be in billion to
May. in protection unchanged from crop Our expectations market for overall we said the what remain
expect XXXX. low-single continue protection in to U.S. flat global basis digit dollar up the crop a We be on market chemical to to
Europe to and Latin up be digit, We be America expect down to digit. North to low to be be America mid-single to up mid-single flat digits, to up high-single mid low-single Asia to digits,
of in rate expected Solutions $XXX third low-single range in low-double FMC, be in fourth to be million segment range $X.X million These of to QX expected digit billion. revenue to in quarter is revenue QX. and and Ag of $XXX $XXX the forecasts is pro growth forma For digit million, represent revenue quarter to the
we integration closings is our is into for In laws. The moving sites and on. process, delayed delayed legal for magnified under major with closings. planned by countries local are and Since DuPont DuPont, due entity, and close lowest market, countries to permit third sales known is will now have of low certain are from and transfers this the there the our and along operating of the delayed internal a period registration and any XXXX, transaction FMC season the the with expect for the often we the as grow sales a events blackout be it of In second quarter sites majority occur the market sites quarter sales basis. on QX. X% our FMC's temporary are countries These to we QX. a creating registration in versus in first and Ag licenses will being protection half half permits, in crop revenues continue in majority to thus XXXX of The will pro outperformance QX. FMC sales on under related of economic this forma Solution receiving QX, are direction, and behalf benefit. which transferred
as our to in $XXX We target, forecasted million is is Brazil, have high has million America, in the our the we full roughly expected past very QX. $XXX visibility and XX% meaningfully EBITDA confidence of have XX% in what In increased our above $XXX seen reach in year seasons. to of in versus QX, range particular, which forecast our be $XXX in and which hand million in revenue previous into million represents have for in years. period, of to orders range the Segment of we over Latin
in of XX% nearly of business, half. ratio of acquired occurred year. years the is first the a XX% the in half. shift were implies is on by half driven This which The segment generated weighted in guidance of Ag XXXX when reversal the much Solutions' EBITDA first heavily is the first more previous Our the earnings
increase Lithium, we million, expect of in $XXX over midpoint. XX% $XXX range segment year to year-over-year at million revenue the of Moving to the to be full a
are We XX% to forecast $XXX midpoint. EBITDA full million year-over-year of of our a at by to $XXX a increasing million the increase year million, range $X represents which
Andrew. $XX representing and EBITDA increase the the I each of is a million for be to now to revenue and between $XXX call the year-over-year segment Our to XX% million, turn will $XX million at to guidance million $XXX in be of for the over QX midpoint. range